Anticancer Agents

The Association of Community Cancer Centers has announced its 2023 advocacy agenda, which includes four core focus areas to ensure members can provide quality, equitable cancer care in a variety of therapeutic settings.

An increasing number of oral anticancer drugs have been granted FDA approval and introduced into clinical practice.